Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking

Naringenin is probable active compound in CSS and SIRT1 is the hub gene by which CSS is involved in NASH treatment.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy and Pharmacology
Published
2024-09-09
DOI
https://doi.org/10.1093/jpp/rgae103
Citations
2
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking

Yi Ren, Yujia Lu, Kaihui Xiao, Wei Chen et al.
2 citations
Journal of Pharmacy and Pharmacology
Liver Disease Diagnosis and Treatment
0.77
article

Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking

Yi Ren, Yujia Lu, Kaihui Xiao, Wei Chen, Li Li, Jingjie Zhao
article en
2 citations

Abstract

Naringenin is probable active compound in CSS and SIRT1 is the hub gene by which CSS is involved in NASH treatment.

Journal of Pharmacy and PharmacologyVol. 76(11)
Capital Medical University (CN), Beijing Friendship Hospital (CN), Beijing Hospital of Traditional Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 26%
Liver Disease Diagnosis and Treatment
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.